Resonance energy transfer assay with cleavage sequence and spacer
A molecular construct comprises a donor label, an acceptor label, a linker peptide disposed between the donor and the acceptor, the linker having a cleavage site sequence, and a spacer between at least one of (a) the donor and the cleavage site sequence and (b) the acceptor and the cleavage site sequence. Preferably, the construct is selected from the group consisting of CFP-(SGLRSRA)-SNAP-25-(SNS)-YFP, and CFP-(SGLRSRA)-synaptobrevin-(SNS)-YFP. In preferred embodiments, the linker peptide is a substrate of a botulinum neurotoxin selected from the group consisting of synaptobrevin (VAMP), syntaxin and SNAP-25, or a fragment thereof that can be recognized and cleaved by the botulinum neurotoxin. Advantageously, the spacer increases the electronic coupling between the donor label and the acceptor label relative to a corresponding construct without the spacer.
1. A method of improving sensitivity of energy transfer between a donor label and an acceptor label, comprising:
providing a first construct comprising the donor label and the acceptor label physically coupled through a linker, wherein the linker comprises an amino acid sequence at least 55 amino acids in length and comprising a cleavage site sequence and a flexible spacer sequence, wherein the spacer sequence is interposed between at least one of the group consisting of the donor label and the cleavage site and the acceptor label and the cleavage site;
contacting the first construct with a sample, wherein the sample comprises an activity directed to the cleavage site;
detecting a fluorescene emission from the first construct, thereby
characterizing an energy transfer between the donor label and the acceptor label,
wherein the energy transfer is enhanced relative to that of a second construct that does not include a spacer sequence.
2. The method of claim 1 , wherein the construct is a protein-based construct, and the linker is a peptide sequence.
3. The method of claim 1 , wherein the cleavage site sequence comprises a SNARE protein, or a fragment or mutein thereof, and wherein the spacer comprises at least five amino acids.
4. The method of claim 1 , wherein the spacer includes a sequence selected from the group consisting of (GGGGS)n [Seq ID 7] and (EAAAK)n [Seq ID 8], where n is 1-3.
5. The method of claim 1 , wherein the spacer increases the electronic coupling between the donor and the acceptor by reducing a tertiary structure distance between the donor and the acceptor.
6. The method of claim 1 , wherein the spacer increases the electronic coupling between the donor and the acceptor by providing an electronic hop between the donor and the acceptor.
7. The method of claim 1 , wherein an assay is applied to whole cells.
8. A method for detecting a botulinum neurotoxin, the method comprising,
a) providing a construct comprising a donor label and an acceptor label physically coupled through a linker, wherein the linker comprises an amino acid sequence at least 55 amino acids in length and comprising a cleavage site sequence and a flexible spacer sequence, wherein the flexible spacer sequence is interposed between the cleavage site and at least one of the group consisting of the donor label and acceptor label, and wherein the cleavage site sequence is at least a cleavable portion of a substrate protein the botulinum neurotoxin to be detected, b) exposing the construct to a sample suspected of containing the botulinum neurotoxin under a condition under which the botulinum neurotoxin cleaves the cleavable portion of the substrate protein, and c) detecting and comparing a FRET signal before and after the construct is exposed to the sample, wherein a decrease in FRET indicates the presence of botulinum neurotoxin in the sample.